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Context: Salivary T (Sal-T) measurement by liquid chromatography–tandem mass spectroscopy
resents the opportunity to examine health correlates of Sal-T in a large-scale population survey.
Objective: This study sought to examine associations between Sal-T and health-related factors in
men and women age 18–74 years.
Design and Setting: Morning saliva samples were obtained from participants in a cross-sectional
probability-sample survey of the general British population (Natsal-3). Self-reported health and
lifestyle questions were administered as part of a wider sexual health interview.
Participants: Study participants included 1599 men and 2123 women.
Methods: Sal-T was measured using liquid chromatography–tandem mass spectroscopy. Linear
regression was used to examine associations between health factors and mean Sal-T.
Results: In men, mean Sal-T was associated with a range of health factors after age adjustment, and
showed a strong independent negative associationwith bodymass index (BMI) inmultivariable anal-
ysis. Men reporting cardiovascular disease or currently taking medication for depression had lower
age-adjustedSal-T, althoughtherewasnoassociationwithcardiovasculardiseaseafteradjustment for
BMI. The decline in Sal-T with increasing age remained after adjustment for health-related factors. In
women, Sal-T declined with increasing age; however, there were no age-independent associations
with health-related factors or specific heath conditions with the exception of higher Sal-T in smokers.
Conclusions: Sal-T levels were associated, independently of age, with a range of self-reported
healthmarkers, particularly BMI, inmen but not women. The findings support the view that there
is an age-related decline in Sal-T in men and women, which cannot be explained by an increase in
ill health. Our results demonstrate the potential of Sal-T as a convenient measure of tissue andro-
gen exposure for population research. (J Clin Endocrinol Metab 101: 3939–3951, 2016)
In men, T deficiency with pituitary or testicular disease(male hypogonadism) is known to cause a wide range
of symptomsandconditions including sexual dysfunction,
loss of vigor, poor physical performance, fractures, and
low mood, which can be effectively treated with testos-
terone replacement therapy (TRT) (1).However, themore
general relationship betweenmale T levels and ill-health is
less well understood. Community-based studies in men
have shown associations between lower average serum
testosterone (serum-T) and poorer health outcomes, in-
cluding frailty, obesity, insulin resistance, cardiovascular
diseases, andmortality, although findings have not always
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been consistent (2–5). It is suggested that lower T levels in
older men may contribute to these ageing-related condi-
tions although questions remain about direction and cau-
sality (3). Some studies have also cast doubt as to whether
there truly is an independent age-related decrease in T, or
whether the observed decline is a biomarker of accumu-
lated comorbidities (6). Currently, whether T treatment
would benefit symptomatic oldermenwith lowT remains
a subject of intense debate and research (7, 8).Many of the
existing studies have been carried out in middle-age or
older men, and the health implications of lower T in
younger men are unclear. In women, circulating concen-
trations of T are typically around 5–10% of those in men,
with distinct age-related declines, independent of the
menopause (9, 10). The evidence for associations between
T and health in women is even more equivocal than for
men (10–13). Furthermore, research efforts in women
have been seriously hampered by inadequate sensitivity of
serum-T measurements, due to the low concentration
of T and poor specificity of commonly used immunoassay
methods (14).
Salivary testosterone (Sal-T) is believed to represent tis-
sue hormone levels, which are unaffected by variations in
circulating binding proteins (15), thereby providing an
alternative to serum free testosterone (free-T) in the as-
sessment of androgen status. In contrast to the collection
of serum, which is invasive and expensive, collection of
saliva is relatively straightforward and requires minimal
training.We have recently demonstrated that Sal-T can be
reliably and accurately measured by a highly sensitive and
specific liquid chromatography–tandem mass spectrome-
try method (16). In a validation study comparing samples
from the same individuals, we found that Sal-T in adult
men andwomen correlatedmore strongly with calculated
serum free-T than serum total-T (17) and was also unaf-
fected by variations in sex hormone-binding globulin
(SHBG) (18). Fiers at al (19) confirmed the good correla-
tion in both men and women between Sal-T and serum
free-T measured by equilibrium dialysis but there was a
significant systematic positive bias in women, which may
reflect the influence of salivary protein binding on the
lower female concentrations of Sal-T. The physiological
and health-related behavioral correlates of Sal-T have not
yet been explored.
Using data from the third National Survey of Sexual
Attitudes and Lifestyles (Natsal-3), a probability-sample
survey of British men and women, we investigated
whether Sal-T is associated, independently of age, with
demographic characteristics, lifestyle, general health, and
reported health conditions. We hypothesized that rela-
tionships between Sal-T and health-related factors in men
would be similar to those previously observed with serum
free-T. To our knowledge, this is the first study to have
examined the associations between Sal-T and health in a
large community sample ofmenandwomenusing ahighly
sensitive and specific assay, exploiting the theoretical and
practical advantages of salivary measurements to the full.
Materials and Methods
Participants and procedures
Full details of the Natsal-3 methods, including details of the
saliva sample collection and testing, are described elsewhere (20,
21). Briefly, Natsal-3was a probability-sample survey of 15 162
men and women age 16–74 years resident in Britain. Interviews
took place between September 2010 and August 2012 using a
combination of computer-assisted personal interviewing and
computer-assisted self-interview for the more-sensitive ques-
tions. The response rate was 57.7%.
Single morning saliva samples were self collected from a sub-
sample of men and women age 18–74 years who did not regu-
larly work night shifts. Consenting participants were given a
self-collection pack and asked to provide their sample before
10:00 hours, to minimize diurnal variation in T (7). They were
asked not to brush their teeth, eat, or chew before giving the
sample, and to spit directly into a plain polystyrene tube. Saliva
samples were posted to the laboratorywhere theywere prepared
and frozen at 80°C until analysis. On receipt of the sample,
participants were sent a £5 voucher as a token of appreciation.
Altogether, 9170 eligible participants were invited to provide a
saliva sample: 6515 (71.0%) agreed to do so and 4591 samples
were received by the laboratory and matched to the survey data
(50.1% of those invited). A total of 463 samples were excluded
due to sample quality issues (insufficient volume [n 154]; sam-
ple discolored/bloody [n  91]; sample recorded as taken after
10:30 hours [n  34]; period between sample being taken and
received by the laboratory more than 5 days or unknown due to
missing date of collection [n 172]; not tested due to error [n
12]) leaving 4128 participants (45.0% of those invited) with a T
result (1675 men; 2453 women). This paper examines associa-
tions between Sal-T and health in the general population; there-
fore, 76 men and 330 women with clinical conditions or taking
medication likely to affect T levels were excluded from analysis
(individuals may be excluded for more than one reason): cur-
rently taking medication for epilepsy (15 men; 15 women) or
prostate disease (43 men); treatment for ovarian, testicular, or
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pituitary condition (16men; 23women) or for polycystic ovaries
(35 women) in the past year; pregnant at interview (42 women);
current receipt of hormone replacement therapy (62 women);
ever receipt of hormone replacement therapy together with hav-
ing had a hysterectomy (proxy measure for having had ovaries
removed; 181 women); missing data for these questions (three
men; 15 women); resulting in 1599men and 2123 women being
included in the analysis. These exclusions aimed to minimize
confounding of the relationship between T and health caused by
these factors which are known to influence T levels, while re-
taining an otherwise-representative sample of the general pop-
ulation.Women taking hormonal contraception (HC) (oral con-
traceptive pill, mirena, injections, implants, or the contraceptive
patch) were included in analyses to allow examination of the
relationship between HC and sal-T, and to avoid biases which
may result from excluding this substantial proportion of women
(24%of all womenwith a valid saliva sample usually used aHC,
and this was 67% in the youngest age group [age 18–24 y]).
However, additional sensitivity analyses were carried out ex-
cluding women taking HC, to assess whether their inclusion af-
fected associations with health factors.
Measures
Health and medication questions were self reported, and
bodymass index (BMI) was calculated from self-reported height
and weight. Due to small numbers of underweight individuals
(BMI18.5kg/m2), theseparticipantswere excluded fromanal-
ysis of BMI (14 men and 44 women). Most of the health ques-
tionswere asked in the computer-assisted personal interviewing,
with the exception of depressive symptoms (past 2weeks) which
were assessed in the computer-assisted self interview using a val-
idated two-itempatient health questionnaire (PHQ-2) (22). Car-
diac, vascular disease, or hypertensionwere defined as ever being
given such diagnoses by a doctor.
Season of data collection was included as a potential con-
founder, defined as: Winter (December, January, February),
Spring (March, April, May), Summer (June, July, August), Au-
tumn (September, October, November).
The liquid chromatography–tandem mass spectroscopy
Sal-T assay was developed using strict validation criteria (23),
with a lower limit of quantification of 6.5 pmol/L. Full details of
the laboratory methods, including the validation of the assay,
have been published elsewhere (17, 18, 20).
Statistical analyses
Statistical analyses were carried out using STATA (version
13.1) accounting for the complex survey design (stratification,
clustering, and weighting of the sample) (24). We applied two
weights: the survey weight corrected for unequal probability of
selection anddifferential response (by age, sex, and region) to the
survey itself; the additional saliva weight corrected for unequal
probability of selection and differential response to the saliva
sample. Factors found to be associated with providing a usable
saliva sample included age at interview, ethnicity, self-reported
general health, and sexual function; the salivaweighting reduced
these biases (20).
Descriptive statistics are presented as means (SEs), with mul-
tivariable linear regression used to assess differences between
groups. Throughout, we censored very high Sal-T values so that,
for each 10-year age group stratified by sex, values above the
99th percentile were assigned a value equal to that of the 99th
percentile. The Sal-T data for men were normally distributed;
however, the distribution for women was positively skewed and
so values were transformed on the natural log scale for analysis.
Accordingly, for men we present linear regression coefficients
representing differences in mean T in pmol/L, whereas for
womenwepresent ratios of geometricmean Sal-T obtained from
exponentiated coefficients. Interval regressionwasused toassign
values to the range 0 to 6.5 pmol/L for three men, and 0.5 (to
allow log transformation) to 6.5 pmol/L for 62 women with T
levels below the limit of detection (6.5 pmol/L). Age was ad-
justed for using both linear and quadratic terms to account for a
nonlinear relationship of T with age.
Given that several associations were found for men, multi-
variable analyses were used to determine which health factors
were independently associated with Sal-T. Variables were
grouped into a series of domains, to identify their individual
contributions to the overall relationships with Sal-T after ad-
justment for earlier domains. The domains were: 1) age and
season, 2) relationship status and children, 3) BMI, and 4) gen-
eral health. A fifth lifestyle domain (smoking, alcohol consump-
tion, drug use) contained no significant associations (either age
adjusted ormultivariable) andwas therefore not presented in the
final multivariable table.Within each domain the variables were
entered into a forward stepwise model selection process (signif-
icance level for inclusion P  .1) with variables selected from
earlier domains included with certainty. The ordering of do-
mains began with factors for which the evidence of association
was best established (from earlier publications) or of a demo-
graphic nature, and then proceeded to health-related factors. In
this way, any identified associations between Sal-T and health
couldbe seenas robust andnot explainedby confounding factors
in other domains. An equivalent analysis was not performed for
women given the lack of age-adjusted associations. In further
analysis we examined associations between specific health con-
ditions or medical treatments and Sal-T, adjusting firstly for age
and then for those factors that had been cumulatively selected
from domains 1 to 3.
Ethics
The Natsal-3 study was approved by the Oxfordshire Re-
search Ethics Committee A (reference: 09/H0604/27). Written
informed consent was obtained for anonymized testing of saliva
samples, without return of results.
Results
Age-adjusted associations of demographic
and general health factors with mean Sal-T
(Tables 1 and 2; Figures 1 and 2)
For both men and women, mean Sal-T decreased with
increasing age, and seasonal variation was observed.
Among men, there was variation in mean sal-T by rela-
tionship status after adjustment for age, with the highest
levels among those who were not currently in a steady
relationship, and lowest levels among those who were
married or cohabiting (age-adjusted linear regression co-
efficient for those not in a steady relationship, compared
with those married/cohabiting: 20.12 (95% confidence
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Table 1. Sample Characteristics, Mean Sal-T, and Associations Between Sal-T and Demographic and Health
Factors: Men
Characteristics
Denominators, n
SE
Mean Sal-T,
pmol/L
Age-Adjustedc
Coefficients 95% CIunwt wt
All men 1599 1886 3.33 223.49
Age, season, region
Age group P  .0001
18–24 y 186 242 9.14 315.81 1.00 —
25–34, y 245 328 7.77 264.62 51.19 (74.44, 27.94)
35–44, y 236 363 8.42 234.16 81.65 (105.90, 57.41)
45–54, y 297 388 5.11 205.74 110.08 (130.78, 89.37)
55–64, y 330 334 4.34 174.63 141.18 (160.84, 121.52)
65–74, y 305 231 3.74 151.72 164.09 (183.51, 144.68)
Season P  .0360
Winter 400 500 6.93 235.15 1.00 —
Spring 464 521 6.09 223.77 5.75 (20.90, 9.40)
Summer 421 457 6.02 207.52 20.73 (36.74, 4.72)
Autumn 314 408 6.40 226.74 2.95 (19.42, 13.52)
Region P  .2432
Scotland and North of England 558 639 5.74 230.52 1.00 —
Midlands and Wales 355 391 6.48 224.33 7.20 (21.22, 6.81)
East of England and South of England 686 856 5.17 217.86 11.08 (24.14, 1.99)
Relationship and children
Relationship status P  .0103
Married/civil partnership/cohabiting 928 1277 3.95 206.71 1.00 —
Steady relationship, not living together 187 179 8.34 263.63 14.62 (1.89, 31.13)
Not in a steady relationship 459 405 6.97 261.46 20.12 (6.41, 33.82)
Any natural children P  .374
No 642 736 5.99 256.27 1.00 —
Yes 928 1104 3.62 204.97 5.80 (18.61, 7.00)
Lives with a child (age  18 y) P  .7611
No 1281 1342 3.76 220.84 1.00 —
Yes 318 544 6.18 230.05 2.17 (16.21, 11.86)
BMI
BMIa P  .0001
Normal (BMI 18.5–25 kg/m2) 599 723 5.07 253.68 1.00 —
Overweight (BMI 25–30 kg/m2) 612 715 4.09 209.82 23.63 (34.81, 12.46)
Obese (BMI  30 kg/m2) 334 365 5.72 174.34 51.26 (64.64, 37.88)
General health and function
Self-reported general health P  .0054
Very good/good 1253 1510 3.83 232.72 1.00 —
Fair/bad/very bad 346 375 5.08 186.37 16.14 (27.50, 4.78)
Longstanding illness or disability P  .0131
No 977 1251 4.15 238.63 1.00 —
Yes 621 634 4.54 193.69 13.36 (23.91, 2.81)
Difficulty walking up stairs because of a health problem P  .0499
No difficulty 1369 1643 3.59 230.41 1.00 —
Some difficulty 166 177 7.60 182.11 8.31 (23.34, 6.71)
Much difficulty or unable 64 66 12.08 162.09 23.74 (44.08, 3.41)
No. of comorbid conditionsb P  .0073
0 913 1169 4.38 245.12 1.00 —
1 397 435 5.87 201.40 11.10 (24.18, 1.98)
2 289 282 5.49 167.97 21.57 (35.10, 8.04)
Lifestyle
Current smoker P  .6599
No 1247 1458 3.60 219.63 1.00 —
Yes 352 428 7.20 236.67 3.01 (10.42, 16.45)
Average alcohol consumption per wk P  .3611
None 295 343 7.44 213.51 1.00 —
Not more than recommended 1130 1352 3.98 226.02 9.51 (5.57, 24.59)
More than recommended 167 183 9.83 223.35 14.50 (7.32, 36.32)
Taken non-prescribed drugs, past y P  .7584
No 1363 1585 3.52 218.03 1.00 —
Yes 197 244 9.03 264.34 2.89 (15.56, 21.34)
Abbreviations: unwt, unweighted; wt, weighted.
a Those with BMI  18.5 kg/m2 have been excluded from analysis due insufficient numbers to analyze this group separately.
b Measure of comorbidity includes arthritis, heart attack, coronary heart disease, angina, other forms of heart disease, hypertension, stroke,
diabetes, broken hip or pelvis bone or hip replacement ever, backache lasting longer than 3 months, any other muscle or bone disease lasting
longer than 3 months, treatment for depression, treatment for cancer, and treatment for any thyroid condition in the past year.
c Adjusted for age and age squared to account for nonlinear relationship between T and age.
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Table 2. Sample Characteristics, Mean Sal-T, and Associations Between Sal-T and Demographic and Health
Factors: Women
Characteristics
Denominators, n
SE
Mean Sal-T,
pmol/L
Age-Adjusted
Ratiosc 95% CIunwt wt
All 2123 1899 0.86 37.09
Age, season, region
Age group P  .0001 P  .0001
18–24 y 231 252 4.15 49.98 1.00 —
25–34, y 390 359 1.82 41.74 0.93 (0.78, 1.12)
35–44, y 391 381 1.92 40.49 0.91 (0.76, 1.09)
45–54, y 408 390 1.55 34.16 0.76 (0.63, 0.91)
55–64, y 378 304 0.98 27.35 0.63 (0.53, 0.75)
65–74, y 325 213 1.25 27.24 0.60 (0.50, 0.72)
Season P  .0001
Winter 529 460 1.09 31.57 1.00 —
Spring 652 556 1.95 37.71 1.15 (1.05, 1.26)
Summer 491 394 1.83 42.46 1.28 (1.16, 1.40)
Autumn 451 489 1.65 37.27 1.09 (0.98, 1.20)
Region P  .2229
Scotland and North of England 741 632 1.19 35.66 1.00 —
Midlands and Wales 475 408 2.19 35.09 0.96 (0.87, 1.05)
East of England and South of England 907 859 1.32 39.10 1.04 (0.96, 1.13)
Relationship and children
Relationship status P  .9109
Married/civil partnership/cohabiting 1203 1234 0.92 35.50 1.00 —
Steady relationship, not living together 257 196 2.39 42.54 1.01 (0.89, 1.14)
Not in a steady relationship 646 449 2.08 39.75 1.02 (0.94, 1.10)
Any natural children P  .6694
No 597 520 2.25 43.25 1.00 —
Yes 1497 1336 0.78 34.67 1.02 (0.93, 1.12)
Lives with a child (age  18 y) P  .5441
No 1409 1179 1.15 35.80 1.00 —
Yes 711 717 1.29 39.09 1.03 (0.94, 1.12)
BMI
BMIa P  .7452
Normal (BMI 18.5–25 kg/m2) 965 870 1.23 39.39 1.00 —
Overweight (BMI 25–30 kg/m2) 586 504 1.37 34.82 0.97 (0.89, 0.94)
Obese (BMI  30 kg/m2) 428 355 1.53 35.13 0.97 (0.90, 0.94)
General health and function
Self-reported general health P  .3880
Very good/good 1753 1560 0.98 37.91 1.00 —
Fair/bad/very bad 370 339 1.65 33.33 0.96 (0.88, 1.05)
Longstanding illness or disability P  .8803
No 1360 1281 1.11 38.21 1.00 —
Yes 763 618 1.37 34.77 1.01 (0.92, 1.10)
Difficulty walking up stairs because of a health problem P  .4682
No difficulty 1787 1598 0.95 38.11 1.00 —
Some difficulty 241 221 2.62 32.92 0.99 (0.87, 1.13)
Much difficulty or unable 95 80 2.79 28.4 0.87 (0.69, 1.09)
No. of comorbid conditionsb P  .5587
0 1177 1101 1.22 39.52 1.00 —
1 546 474 1.33 35.01 0.99 (0.91, 1.08)
2 400 324 2.00 31.91 0.93 (0.82, 1.06)
Lifestyle
Current smoker P  .0165
No 1714 1548 0.82 35.88 1.00 —
Yes 409 351 2.45 42.44 1.11 (1.02, 1.22)
Average alcohol consumption per wk P  .3272
None 640 606 1.57 36.04 1.00 —
Not more than recommended 1280 1113 1.13 37.97 1.06 (0.98, 1.16)
More than recommended 198 175 2.08 35.23 1.02 (0.91, 1.15)
Taken non-prescribed drugs, past y P  .3064
No 1970 1746 0.90 36.68 1.00 —
Yes 115 106 4.01 46.44 1.09 (0.93, 1.28)
Abbreviations: unwt, unweighted; wt, weighted.
a Those with BMI  18.5 kg/m2 have been excluded from analysis due insufficient numbers to analyze this group separately.
b Measure of comorbidity includes arthritis, heart attack, coronary heart disease, angina, other forms of heart disease, hypertension, stroke,
diabetes, broken hip or pelvis bone or hip replacement ever, backache lasting longer than 3 mo, any other muscle or bone disease lasting longer
than 3 mo, treatment for depression, treatment for cancer, and treatment for any thyroid condition in the past year.
c Ratio of geometric means, obtained from exponentiated age-adjusted linear regression coefficients of log-transformed data for women. Adjusted
for age and age-squared to account for nonlinear relationship between T and age.
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interval [CI], 6.41–33.82); no association was found with
having children. There were no associations with demo-
graphic factors for women.
Mean Sal-T was associated, independently of age, with a
range of measures of general health in men but not in
women. In age-stratified analyses of men, mean Sal-T was
seen to be lower with increasing BMI (normal, overweight,
obese) (Figure 1), and somewhat higher in those reporting
good or very good health (Figure 2) at least at younger ages;
these associations were not seen in women. Expressed as
age-adjusted regression coefficients, we found levels were
lower among men who were overweight or obese, (coeffi-
cients 23.63 [34.81 to 12.46]
and 51.26 [64.64 to 37.88] re-
spectively, compared with normal
BMI) reported poorer general health
(16.14 [27.50 to 4.78]), long-
standing illness or disability (13.36
[27.50 to 4.78]); difficulty walk-
ing up stairs (23.74 [44.08 to
3.41] for thosewithmuchdifficulty/
inability, compared with no diffi-
culty), or two or more comorbid
health conditions ([21.57 [35.10 to
8.04) compared with none). There
was no association among men with
smoking, alcohol consumption, or il-
licit drug use.
The only health association found
for women was with smoking, with
higher Sal-T among women who
smoked (ratio of geometric means
1.11 [1.02–1.22] for current smok-
ers compared with nonsmokers).
Women who used HC as their usual
method of contraception had lower
mean Sal-T (geometric mean ratio
compared with those who had not
taken HC: 0.78 [0.70–0.87]; P 
.0001). A sensitivity analysis exclud-
ing women on HC (n  499) pro-
duced generally similar results, al-
though the associationwith smoking
became nonsignificant due to an in-
crease in the size of the confidence
intervals (age-adjusted geometric
mean ratio: 1.08 [0.98–1.19]; P 
.107). Adjusting the women’s anal-
ysis for season as well as age did not
change any of the results (data not
shown).
Multivariable analyses of men
In men, all associations with variables in domains 1–3
in the age-adjusted analyses remained significant in the
multivariable analyses: age, season, relationship status,
and BMI (Table 3). Only one variable from domain
4—self-reported general health—was selected in the
model, although providing inconclusive evidence of an
association (11.39 [22.69 to 0.10] P  .048). In
further exploratory analysis we fitted a model excluding
BMI but including age, season, and relationship status, in
which self-reported general health was found to be more
strongly associated with Sal-T (19.01 [30.48 to
7.54] P  .001; data not shown).
Figure 1. Mean (95% CI) Sal-T (pmol/L) by age group and BMI. Note: figures for men and
women have different scales. A, Men. B, Women.
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Specific health conditions
Cardiovascular disease (including hypertension) was
reportedby19%ofmen inour sample, andwasassociated
with lower mean Sal-T in men, independently of age
(18.06 [29.43 to6.68]) (Table 4). There was also an
association with currently taking medication for depres-
sion (24.56 [48.33 to0.79], reportedby4%ofmen),
but not with current depressive symptoms (10% of men
screened positive for depressive symptoms in the past 2
weeks). After adjustment for age, there was at best weak
evidence of an association with self-reported doctor-diag-
nosed diabetes (reported by 6% of men in our sample).
Further adjustment for season, rela-
tionship status, and BMI attenuated
the association with cardiovascular
disease (8.98 [20.27 to 2.31];
P  .119) and diabetes (5.51
[23.1 to 12.1]; P  .540) but
strengthened the association with
depression medication (28.02
[51.64 to4.40];P .020). There
was no evidence of associations be-
tween Sal-T and any of these condi-
tions among women.
Discussion
Summary of findings and
comparison with other studies
This study is the first to show as-
sociations between Sal-T and health
in a large national probability-sam-
ple surveyofmenandwomen, across
a wide age range. In men, we found
significant age-independent associa-
tions between lower Sal-T and
higher BMI, poorer self-reported
general health, mobility problems,
longstanding illness, and comorbid
conditions (cardiovascular disease,
treatment for depression). The asso-
ciation between Sal-T and self-re-
ported general health in men was at-
tenuated after adjustment for BMI,
suggesting that the relationship is at
least partly explained by obesity.We
found no associations between Sal-T
and health factors in women, except
smoking, with higher Sal-T among
women who smoked.
The present finding of an age-re-
lated decline in Sal-T that persisted
even after adjusting for health and demographic factors is
consistentwith previous serumstudies that foundnot only
serum total-T, but also serum free-T, declined across an
age range in women (9) and men similar to Natsal-3 (24).
Others, however, have argued that the age-related decline
in serum total-T may entirely be explained by declining
health (6). This inconsistency may partly be explained by
the age-related increase in SHBG,whichattenuates the age
trend in total serum-T, but not serum free-T (5) or Sal-T.
Our findings of associationswith health-related factors
in men are largely consistent with evidence from serum
Figure 2. Mean (95% CI) Sal-T (pmol/L) by age group and self-reported general health status.
Note: figures for men and women have different scales. A, Men. B, Women.
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studies. There is a large body of evidence that, in men,
obesity is strongly associated with lower serum-T, inde-
pendently of age (3). Associations have also been reported
between lower serum-T and insulin resistance and diabe-
tes, preclinical indicators for cardiovascular disease, car-
diovascular events, physical frailty, and increasedmortal-
ity (3, 5, 25, 26). Cross-sectional data cannot shed light on
the direction of these relationships but longitudinal stud-
ies have found that obesity leads to decreases in T, and
weight loss increases T levels in obese men (27), although
there is also evidence of bidirectional associations (3).
Longitudinal serum-T studies have shown that low T pre-
cedes cardiovascular events (25). The mechanisms of this
association are unclear and may involve low T affecting
several cardiovascular risk factors, central adiposity, and
inflammation (28). Unlike most serum-T studies we did
not find an age-adjusted association with self-reported di-
abetes for men with P  .0932 indicating at best weak
evidence of an association, which did not persist after ad-
justing for other confounding factors including BMI. Al-
thoughprevalence of diabetes in our samplewas similar to
national estimates (29), the absolute number of men with
diabetes in our sample was relatively small, thus limiting
our power to detect an association. However other re-
search has shown that the apparent association between
diabetes and low serum total-T, but not free-T, may be
Table 3. Adjusted Associations Between Demographic and Health Factors and Salivary Sal-T: Men
Associations
Denominators, n Age-
Adjusted
Coefficients (95% CI)
Domain 1
Adjusted
Coefficientsunwt wt
Age, season, region
Age P  .0001
18–24 y 186 242 1.00 — —
25–34 y 245 328 51.19 (74.44, 27.94) 52.08
35–44 y 236 363 81.65 (105.90, 57.41) 81.66
45–54 y 297 388 110.08 (130.78, 89.37) 109.69
55–64 y 330 334 141.18 (160.84, 121.52) 140.78
65–74 y 305 231 164.09 (183.51, 144.68) 163.73
Season P  .0360
Winter 400 500 1.00 — —
Spring 464 521 5.75 (20.90, 9.40) 5.75
Summer 421 457 20.73 (36.74, 4.72) 20.73
Autumn 314 408 2.95 (19.42, 13.52) 2.95
Relationship and children
Relationship status P  .0103
Married/civil partnership/cohabiting 928 1277 1.00 —
Steady relationship, not living together 187 179 14.62 (1.89, 31.13)
Not in a steady relationship 459 405 20.12 (6.41, 33.82)
Any natural children P  .374
No 642 736 1.00 —
Yes 928 1104 5.80 (18.61, 7.00)
Lives with a child (age  18 y) P  .7611
No 1281 1342 1.00 —
Yes 318 544 2.17 (16.21, 11.86)
BMI
BMI P  .0001
Normal (BMI, 18.5–25 kg/m2) 599 723 1.00 —
Overweight (BMI, 25–30 kg/m2) 612 715 23.63 (34.81, 12.46)
Obese (BMI  30 kg/m2) 334 365 51.26 (64.64, 37.88)
General health and function
Self-reported general health P  .0054
Very good/good 1253 1510 1.00 —
Fair/bad/very bad 346 375 16.14 (27.50, 4.78)
Longstanding illness or disability P  .0131
No 977 1251 1.00 —
Yes 621 634 13.36 (23.91, 2.81)
Difficulty walking up stairs because of a health problem P  .0499
No difficulty 1369 1643 1.00 —
Some difficulty 166 177 8.31 (23.34, 6.71)
Much difficulty or unable 64 66 23.74 (44.08, 3.41)
Number of comorbid conditions P  .0073
0 913 1169 1.00 —
1 397 435 11.10 (24.18, 1.98)
2 289 282 21.57 (35.10, 8.04)
Abbreviations: unwt, unweighted; wt, weighted.
Variables were grouped into a hierarchy of domains as follows: 1. Age, season, region; 2. Relationship status and family; 3. BMI; 4. General health
and function. Lifestyle factors (smoking, drinking, drug use) were not included in the adjusted analysis given lack of associations seen in age-
adjusted analysis.
The variables were entered in these groups in order, and including any variables found to be significant from previous domains, into forwards
stepwise linear (interval) regression models to generate adjusted coefficients. The significance criteria for retention in the model was P  .1.
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confounded by obesity and low SHBG, which is in line
with our findings (30).We found no association with cur-
rent depressive symptoms but did observe an association
with treatment for depression. Little research exists on
the effects of antidepressants on the hypothalamic-pi-
tuitary-gonadal axis, although one study has found
higher Sal-T levels among men and women using selec-
tive serotonin reuptake inhibitors, which contrasts with
our results (31).
We examined associations between Sal-T and several
demographic factors toaddresspotential confoundingof the
associationswithhealth.Aprevious study found ethnic vari-
ation in T levels; however, we were unable to examine this
due to small numbers of participants in ethnic minority
groups. The findings of this study only partly concur with
those from (generally smaller) studies that have reported
lowerT amongmen andwomen in established relationships
(32) and parents, especially those actively involved in child-
care (33, 34).We foundassociationswith relationship status
formenonly, andnoassociationswithparenthood for either
men or women; however, our measures of parenthood cap-
ture a broad range of circumstances regarding children’s age
Table 3. Continued
(95% CI)
Domain 2
Adjusted
Coefficients (95% CI)
Domain 3
Adjusted
Coefficients (95% CI)
Domain 4
Adjusted
Coefficients (95% CI)
P  .0001 P .0001 P .0001 P .0001
— — — — — — —
(75.40, 28.75) 41.05 (65.54,16.56) 33.70 (58.31,9.09) 31.90 (56.44,7.35)
(105.55, 57.78) 69.74 (94.08,45.39) 62.79 (86.52,39.07) 60.66 (84.61,36.71)
(130.35, 89.03) 97.21 (118.62,75.81) 82.80 (104.26,61.35) 79.74 (101.33,58 .16)
(160.37, 121.18) 126.87 (147.78,105.96) 111.77 (132.95,90.59) 107.91 (128.99,86.82)
(183.04, 144.42) 149.80 (170.91,128.70) 134.69 (155.81,113.56) 130.48 (151.83,109.13)
P  .0360 P .0256 P .0368 P .0294
— — — — — — —
(20.90, 9.40) 6.57 (21.79, 8.66) 1.93 (15.68, 11.81) 2.00 (15.76, 11.75)
(36.74, 4.72) 21.48 (37.47,5.49) 16.41 (30.21,2.61) 16.76 (30.56,2.96)
(19.42, 13.52) 2.90 (19.44, 13.64) 1.24 (13.03, 15.52) 1.46 (12.79, 15.71)
P .0073 P .0185 P .0110
— — — — —
16.02 (0.55, 32.58) 11.18 (4.54, 26.91) 11.68 (4.07, 27.42)
20.50 (6.85, 34.15) 18.52 (5.13, 31.91) 20.10 (6.50, 33.70)
P  .0001 P  .0001
— — — —
22.40 (33.63,11.17) 22.33 (33.56,11.11)
49.69 (62.84,36.54) 47.59 (61.22,33.96)
P  .048
— — —
11.39 (22.69,0.10)
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andparents’ involvement inchildrearing,whichmayexplain
this apparent discrepancy.
We found no association between Sal-T and smoking,
alcohol consumption, or drug use in men. Previous se-
rum-T studies inmen have generally, although not always
consistently, shown smoking to be associated with in-
creased total-T, and studies of the associationswith free-T
have yieldedmixed results (35). Smoking, via direct effects
on liver function, increases SHBG levels, which may ex-
plain why total-T is increased in smokers yet in our study
we did not find an associationwith Sal-T inmen (35). The
evidence regarding whether T is associated with alcohol
consumption is also mixed (26, 36), and few studies have
examined associations with other drugs.
Previous research about the health correlates of T in
women has not only yielded inconsistent findings, but has
largely been carried out within narrow age ranges, and
using suboptimal measures of T (14). We found no evi-
dence of associations between Sal-T and general health
indicators, or specific conditions or medications in
women. We did find a positive association with smoking,
which is consistent with other studies (11, 37). We also
found lower mean Sal-T among women who had taken
HC, which can be explained by the combined effects of a
direct inhibitory effect on ovarian androgen synthesis, an
increase in SHBG concentration, and an inhibitory effect
on adrenal androgen production (38). The association be-
tween Sal-T and smoking in women became nonsignifi-
cant after excludingwomenwho had takenHC; however,
the effect estimate was similar, so it is likely that this
change in statistical significant is due to the reduction in
sample size and resulting increase in confidence intervals,
rather than a true difference between these groups of
women.
Our findings regarding the different relationship with
health and obesity for men and women may relate to the
different sites of production and mechanisms of regula-
tion. Among women, T is produced from the adrenal
glands, regulated by adrenocorticotropic hormone, as
well as the ovaries, regulated by gonadotropins, and there
are menstrual cyclical fluctuations of ovarian steroids,
whereas in men T is produced predominantly from the
testes with only a very minor contribution from the adre-
nals. The mechanisms underlying the relationship be-
tween obesity and low T in men remain unclear, although
the potential importance of circulating inflammatory cy-
tokines from visceral adipose depots is gaining credence
(39, 40).
Strengths and limitations
A key strength of this study is the highly sensitive and
specific Sal-T assay, enabling accurate measurement in
women aswell asmen—although there is some systematic
positive bias due to salivary protein binding among
women (19)—and permitting measurement of T on a
large-scale probability-sample survey across a wide age
range. Although less invasive than serum, large-scale
home-based collection of saliva has presented a number of
challenges including coping with the diurnal variation in
T levels, preventing contamination, ensuring prompt re-
Table 4. Associations Between Reporting Specific Health Conditions and Medical Treatments and Sal-T by Sex
Men Women
Denominators,
n
SE
Mean Sal-T,
pmol/L
Age-Adjusted
Coefficients (95% CI)
Denominators,
n
SE
Mean Sal-T,
pmol/L
Age-Adjusted
Ratiosb (95% CI)Unwt Wt Unwt Wt
All 1599 1886 3.33 223.49 2123 1899 0.86 37.09
Any cardiac or vascular
disease or
hypertension
P  .0019 P  .6863
No 1257 1548 3.75 235.47 — — 1789 1625 0.95 37.99 1.00 —
Yes 342 338 4.92 168.6 18.06 (29.43, 6.68) 334 275 1.71 31.79 0.98 (0.88, 1.09)
Diabetes P  .0932 P  .4689
No 1482 1769 3.4 227.47 — — 2036 1828 0.87 37.34 1.00 —
Yes 117 116 8.82 162.98 15.55 (33.71, 2.61) 87 71 2.54 30.67 0.93 (0.77, 1.13)
Currently taking
medication for
depression
P  .0428 P  .5670
No 1513 1810 3.42 224.79   1930 1737 0.92 37.29 1.00 —
Yes 86 75 11.61 192.34 24.56 (48.33, 0.79) 193 163 2.11 34.99 0.97 (0.86, 1.09)
Depressive symptomsa P  .7057 P  .7079
No 1386 1644 3.41 223.84 — — 1864 1646 0.81 37.13 1.00 —
Yes 176 186 11.25 228.68 4.00 (24.77, 16.77) 222 206 3.74 38.04 0.97 (0.85, 1.12)
Abbreviations: unwt, unweighted; wt, weighted.
a Participants were asked whether they had often been bothered by feeling down, depressed, or hopeless in hte past 2 weeks, and whether they
had often been bothered by little interest or pleasure in doing things in the past 2 weeks, using a validated two-question patient health
questionnaire (PHQ-2).
b Ratio of geometric means, obtained from exponentiated age-adjusted linear regression coefficients of log-transformed data for women.
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ceipt at the laboratory before deterioration, and minimiz-
ing nonresponse bias. Considerable attention was paid to
the development of protocols for sample collection, with
extensive validation and piloting (20), yet although
71.0%of participants agreed to provide a sample, useable
samples were received from only 45.0% of those invited,
highlighting the challenge of obtaining self-collected and
self-posted samples. This response rate is similar to com-
munity-based serum T studies (41, 42), and the response
rate to the surveyoverallwas similar toothermajorBritish
social surveys. However, there were some systematic dif-
ferences in the characteristicsof thosewhoreturnedavalid
saliva sample, for example older participants were more
likely to give a sample; therefore, to minimize potential
nonresponse bias, both to the survey and to the saliva
sample,weapplied statisticalweights duringanalysis (20).
The health data collected were self reported and are
therefore reliant on knowledge of conditions and medi-
cations, and accurate reporting. This may particularly af-
fect BMI based on self-reported height and weight, given
thatpeople tend tounderestimateweight andoverestimate
height. However, previous studies have shown self-re-
ported height and weight to be sufficient for examining
associations in epidemiological studies (43). As a sexual
health survey, only a limited number of questions about
general health could be asked; therefore, we were unable
to look at associations with some factors that may have
been of interest such as frailty, osteoporosis, or sleep dis-
turbance. We were also unable to measure preclinical dis-
ease indicators.
Only one sample was collected from each participant
and so we were unable to take into account intra-individ-
ual variation in T levels, which may be particularly rele-
vant for premenopausal women given that T varies
throughout themenstrual cycle (44).However, some have
argued that it is unnecessary to control formenstrual vari-
ation, given the relatively small effects comparedwith, for
example, diurnal variation or individual differences (44).
This is consistent with our earlier validation work in
which we did not find significant within-individual dif-
ferences when samples were taken at weekly andmonthly
intervals (17). A small number ofmen andwomen (n 20
and n 37, respectively) included in our analysis reported
receiving cancer treatment in the past year, and as the
nature of the cancer or treatmentwas unknown, this could
have affected T levels for some. However, given the small
numbers this is unlikely to have affected our findings
overall.
Implications for clinical research, policy, and
additional research need
The findings presented in this paper provide crucial
background for future research into the relationship be-
tween Sal-T and sexual function and sexual behavior, as
well as being important in their own right for understand-
ing associations between Sal-T and health factors. Our
findings are broadly consistent with previous research us-
ing serum, andwhere differences exist it is not always clear
whether these are due to differences in the measure used
(serum total-T, free-T, or Sal-T), or due to other differ-
ences in the study population and design. Further obser-
vational research using reliable saliva T measurements
linked to a broader range of clinical correlates would
strengthen the evidence base in this respect.
There are concerns about inappropriatemarketing and
use of TRT for men, particularly in the United States (7).
Our cross-sectional finding of lower Sal-T among men
with poorer health does not imply causality, nor does it
indicate treatment. Although longitudinal research has
shown that low T precedes poor health outcomes (25) the
benefits of TRT in the general population remain unclear.
Further research is needed before conclusions can be
reached regarding the nature of the relationship between
T and ill health, and the risks and benefits of intervention.
Our finding of an independent age-related decline in
Sal-T suggests that reproductive senescence in men, as in
women, is not solely the consequence of poor health. The
clinical significance of this merits further investigation us-
ing Sal-T as well as serum-T measurements. The applica-
tion of Sal-Tmeasurement in future research shouldmake
a significant contribution toward clarifying the role of low
T in health and ageing in men and women.
Acknowledgments
We thank the study participants; the team of interviewers from
NatCen Social Research, operations and computing staff from
NatCen Social Research; and the study funders. Natsal-3 is a
collaboration between University College London, the London
School of Hygiene & Tropical Medicine, NatCen Social Re-
search, Public Health England (formerly the Health Protection
Agency), and the University of Manchester. The study was sup-
ported by grants from the Medical Research Council
(G0701757); and the Wellcome Trust (084840); with contribu-
tions from the Economic and Social Research Council and De-
partment of Health. We gratefully acknowledge the important
technical contributions of HalinaMcIntyre and Anne Kelly, De-
partment of Clinical Biochemistry, Royal Infirmary, Glasgow
G4 0SF, Scotland, United Kingdom; and PhilipMacdonald, De-
partment of Clinical Biochemistry, University Hospital South
Manchester, Manchester United Kingdom.
S.C. is supported by the National Institute for Health Re-
search (NIHR Research Methods Programme, Fellowships and
Internships, NIHR-RMFI-2014-05-8). N.F. is supported by an
academic clinical lectureship. Since September 2015 K.R.M. has
been core funded by the United Kingdom Medical Research
doi: 10.1210/jc.2016-1669 press.endocrine.org/journal/jcem 3949
The Endocrine Society. Downloaded from press.endocrine.org by [${individualUser.displayName}] on 21 December 2016. at 01:25 For personal use only. No other uses without permission. . All rights reserved.
Council (MRC); MRC/CSO Social & Public Health Sciences
Unit, University of Glasgow (MC_UU_12017-11).
The views expressed in this publication are those of the au-
thor(s) and not necessarily those of the NHS, the National In-
stitute for Health Research or the Department of Health.
Address all correspondence and requests for reprints to:
Soazig Clifton, Centre for Sexual Health and HIV Research,
UCL, 3rd Floor, Mortimer Market Centre, off Capper Street,
London WC1E 6JB. E-mail: s.clifton@ucl.ac.uk.
Disclosure Summary: A.M.J. has been a Governor of the
Wellcome Trust since 2011. F.C.W.W. has acted as a consultant
for Bayer-Schering, Eli Lilly and Besins Healthcare and also par-
ticipated in advisoryboardmeetings and lecturedon their behalf.
F.C.W.W. has received lecture fees from Bayer-Schering and Be-
sins Healthcare. F.C.W.W. has received grant support (2010–
2014) from Bayer Schering AG and Besins Healthcare. S.C.,
W.M., A.J.C., C.T., B.G.K., D.M.L., K.R.M., N.F., P.S., J.B.,
C.H.M., A.M.W., and K.W. have nothing to disclose.
References
1. Bhasin S, CunninghamGR, Hayes FJ, et al. Testosterone therapy in
men with androgen deficiency syndromes: An Endocrine Society
Clinical Practice Guideline. J Clin Endocrinol Metab. 2010;95(6):
2536–2559.
2. O’Connell MD, Wu FC. Androgen effects on skeletal muscle: Im-
plications for the development and management of frailty. Asian J
Androl. 2014;16(2):203–212.
3. Yeap BB, Araujo AB, Wittert GA. Do low testosterone levels con-
tribute to ill-health duringmale ageing?Crit RevClin Lab Sci. 2012;
49(5–6):168–182.
4. Haring R, Baumeister SE, Völzke H, et al. Prospective inverse as-
sociations of sexhormone concentrations inmenwithbiomarkers of
inflammation and oxidative stress. J Androl. 2012;33(5):944–950.
5. Wu FC, Tajar A, Pye SR, et al. Hypothalamic-pituitary-testicular
axis disruptions in older men are differentially linked to age and
modifiable risk factors: The European Male Aging Study. J Clin
Endocrinol Metab. 2008;93(7):2737–2745.
6. Sartorius G, Spasevska S, Idan A, et al. Serum testosterone, dihy-
drotestosterone and estradiol concentrations in older men self-re-
porting very good health: The healthy man study. Clin Endocrinol.
(Oxf. 2012) 77(5):755–763.
7. NguyenCP,HirschMS,MoenyD,Kaul S,MohamoudM, JoffeHV.
Testosterone and “Age-Related Hypogonadism”—FDA Concerns.
N Engl J Med. 2015;373(8):689–691.
8. Kamerow D. Getting your “T” up. BMJ. 2014;348:g182–g182.
9. Haring R, Hannemann A, John U, et al. Age-specific reference
ranges for serum testosterone and androstenedione concentrations
in women measured by liquid chromatography-tandem mass spec-
trometry. J Clin Endocrinol Metab. 2012;97(2):408–415.
10. Davison SL, Bell R, Donath S, Montalto JG, Davis SR. Androgen
levels in adult females: Changes with age, menopause, and oopho-
rectomy. J Clin Endocrinol Metab. 2005;90(7):3847–3853.
11. Sowers MF, Beebe JL, McConnell D, Randolph J, Jannausch M.
Testosterone concentrations in women aged 25–50 years: Associa-
tions with lifestyle, body composition, and ovarian status. Am J
Epidemiol. 2001;153(3):256–264.
12. Sutton-Tyrrell K, Wildman RP, Matthews KA, et al. Sex hormone–
binding globulin and the free androgen index are related to cardio-
vascular risk factors in multiethnic premenopausal and perimeno-
pausal women enrolled in the Study of Women Across the Nation
(SWAN). Circulation. 2005;111(10):1242–1249.
13. Santoro N, Torrens J, Crawford S, et al. Correlates of circulating
androgens inmid-lifewomen: The Study ofWomen’sHealthAcross
the Nation. J Clin Endocrinol Metab. 2005;90(8):4836–4845.
14. WiermanME,BassonR,Davis SR, et al.Androgen therapy inWom-
en: An Endocrine Society Clinical Practice Guideline. J Clin Endo-
crinol Metab. 2006;91(10):3697–3710.
15. Vining RF, McGinley RA, Symons RG. Hormones in saliva: Mode
of entry and consequent implications for clinical interpretation.Clin
Chem 1983;29(10):1752–1756.
16. Macdonald PR,Owen LJ,Wu FC,MacdowallW, Keevil BG,NAT-
SAL Team. A liquid chromatography–tandem mass spectrometry
method for salivary testosterone with adult male reference interval
determination. Clin Chem. 2011;57(5):774–775.
17. Keevil BG, MacDonald P, Macdowall W, Lee DM, Wu FCW, the
NATSAL Team. Salivary testosterone measurement by liquid chro-
matography tandemmass spectrometry in adult males and females.
Ann Clin Biochem Int J Biochem Lab Med. 2014;51(3):368–378.
18. Keevil BG, Fiers T, Kaufman JM, et al. Sex hormone–binding glob-
ulin has no effect on salivary testosterone [published online
ahead of print April 26, 2016]. Ann Clin Biochem. doi:10.1177/
0004563216646800.
19. Fiers T, Delanghe J, T’SjoenG, Van Caenegem E,Wierckx K, Kauf-
man JM. A critical evaluation of salivary testosterone as a method
for the assessment of serum testosterone. Steroids. 2014;86:5–9.
20. ErensB, PhelpsA,CliftonS, et al.National surveyof sexual attitudes
and lifestyles 3: Technical report. London:NatCen Social Research;
2013.
21. Erens B, Phelps A, Clifton S, et al.Methodology of the third British
National Survey of Sexual Attitudes and Lifestyles (Natsal-3). Sex
Transm Infect. 2014;90(2):84–89.
22. Arroll B, Khin N, Kerse N. Screening for depression in primary care
with two verbally asked questions: Cross sectional study. BMJ.
2003;327(7424):1144–1146.
23. Gao J. Bioanalytical method validation for studies on pharmacoki-
netics, bioavailability and bioequivalence: Highlights of the FDA’s
Guidance. Asian J Drug Metab Pharmacokinet. 2004;4(1):5–13.
24. Stata Statistical Software: Release 13. College Station, TX: Stat-
Corp; 2013.
25. Khaw KT, Dowsett M, Folkerd E, et al. Endogenous testosterone
and mortality due to all causes, cardiovascular disease, and cancer
in men: European prospective investigation into cancer in Norfolk
(EPIC-Norfolk) Prospective Population Study. Circulation. 2007;
116(23):2694–2701.
26. AllenNE, Appleby PN,DaveyGK, KeyTJ.Lifestyle and nutritional
determinants of bioavailable androgens and related hormones in
British men. Cancer Causes Control. 2002;13(4):353–363.
27. Camacho EM, Huhtaniemi IT, O’Neill TW, et al. Age-associated
changes in hypothalamic-pituitary-testicular function in middle-
aged and older men are modified by weight change and lifestyle
factors: Longitudinal results from the EuropeanMaleAgeing Study.
Eur J Endocrinol. 2013;168(3):445–455.
28. Jones TH. Testosterone deficiency: A risk factor for cardiovascular
disease? Trends Endocrinol Metab. 2010;21(8):496–503.
29. Craig R, Mindell J. Health Survey for England 2011. London,
UK: The NHS Information Centre for health and social care;
2012. Available at: http://www.hscic.gov.uk/catalogue/PUB09300/
HSE2011-Sum-bklet.pdf. Accessed April 14, 2016.
30. Antonio L, Wu FCW, O’Neill TW, et al. Low free testosterone is
associated with hypogonadal signs and symptoms in men with nor-
mal total testosterone. J Clin Endocrinol Metab. 2016:jc.2015-
4106.
31. Giltay EJ, Enter D, Zitman FG, et al. Salivary testosterone: associ-
ations with depression, anxiety disorders, and antidepressant use in
a large cohort study. J Psychosom Res. 2012;72(3):205–213.
32. van Anders SM, Goldey KL.Testosterone and partnering are linked
via relationship status for women and ‘relationship orientation’ for
men. Horm Behav. 2010;58(5):820–826.
33. Gettler LT, McDade TW, Feranil AB, Kuzawa CW. Longitudinal
3950 Clifton et al Salivary Testosterone and Health in British Men and Women J Clin Endocrinol Metab, November 2016, 101(11):3939–3951
The Endocrine Society. Downloaded from press.endocrine.org by [${individualUser.displayName}] on 21 December 2016. at 01:25 For personal use only. No other uses without permission. . All rights reserved.
evidence that fatherhood decreases testosterone in human males.
Proc Natl Acad Sci. 2011;108(39):16194–16199.
34. Barrett ES, TranV, Thurston S, et al.Marriage andmotherhood are
associatedwith lower testosterone concentrations in women.Horm
Behav. 2013;63(1):72–79.
35. Kapoor D, Jones TH. Smoking and hormones in health and endo-
crine disorders. Eur J Endocrinol. 2005;152(4):491–499.
36. Svartberg J, Midtby M, Bønaa KH, Sundsfjord J, Joakimsen RM,
JordeR.The associations of age, lifestyle factors and chronic disease
with testosterone in men: the Tromsø Study. Eur J Endocrinol.
2003;149(2):145–152.
37. Barbieri RL, Sluss PM, Powers RD, et al. Association of body mass
index, age, and cigarette smoking with serum testosterone levels in
cycling women undergoing in vitro fertilization. Fertil Steril. 2005;
83(2):302–308.
38. Zimmerman Y, EijkemansMJ, Coelingh Bennink HJ, Blankenstein
MA, Fauser BC. The effect of combined oral contraception on tes-
tosterone levels in healthy women: A systematic review and meta-
analysis. Hum Reprod Update. 2014;20(1):76–105.
39. Veldhuis J, Yang R, Roelfsema F, Takahashi P. Proinflammatory
cytokine infusion attenuates LH’s feedforward on testosterone se-
cretion:Modulation by age. J Clin EndocrinolMetab. 2016;101(2):
539–549.
40. Dhindsa S, Batra M, Kuhadiya N, Dandona P. Oestradiol concen-
trations are not elevated in obesity-associated hypogonadotrophic
hypogonadism. Clin Endocrinol (Oxf). 2014; 80(3):464.
41. Feldman HA, Longcope C, Derby CA, et al. Age trends in the level
of serum testosterone andother hormones inmiddle-agedmen:Lon-
gitudinal results from the Massachusetts Male Aging Study. J Clin
Endocrinol Metab. 2002;87(2):589–598.
42. Lee DM, O’Neill TW, Pye SR, et al. The European Male Ageing
Study (EMAS): Design, methods and recruitment. Int J Androl.
2009;32(1):11–24.
43. Spencer EA, Appleby PN, Davey GK, Key TJ. Validity of self-re-
ported height andweight in 4808 EPIC-Oxford participants. Public
Health Nutr. 2002;5(4):561–565.
44. van Anders SM, Goldey KL, Bell SN.Measurement of testosterone
in human sexuality research: Methodological considerations. Arch
Sex Behav. 2014;43(2):231–250.
doi: 10.1210/jc.2016-1669 press.endocrine.org/journal/jcem 3951
The Endocrine Society. Downloaded from press.endocrine.org by [${individualUser.displayName}] on 21 December 2016. at 01:25 For personal use only. No other uses without permission. . All rights reserved.
